RE: Short Squeeze5 Oct 2021 16:36
My conclusions remain the same and I believe Avacta is going strongly. Tomorrow we will be 1 week away from the next cycle for AVA6000. I maintain the following view. The strong conclusion we can draw from the last week is that both the therapeutics and diagnostics arm is about to announce news. With AVA6000 progressing well (Presentation), Affidx for sale to Gov. Departments (Medusa website), LG Chem providing a resounding endorsement of Avacta (RNS Wed), HUA submitted and ready to go, this looks like a very strong momentum.